Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
CSF2RA (Colony stimulating factor 2 receptor subunit alpha) encodes a single pass type I transmembrane glycoprotein belonging to the cytokine receptor superfamily. Predominantly expressed within hematopoietic related cell populations, its expression profile also extends to several non hematopoietic compartments, reflecting broad cellular responsiveness to relevant extracellular signalling cues. The receptor is built with large extracellular structural modules for molecular partner recognition, one transmembrane spanning segment, and a short intracellular fragment capable of recruiting diverse cytosolic effector molecules upon complex formation. Following biosynthesis, newly synthesized CSF2RA undergoes folding, glycosylation and endoplasmic reticulum Golgi quality control processing. A fraction of mature receptor molecules is transported and anchored onto plasma membrane surfaces, whereas remaining protein pools are retained inside intracellular vesicle compartments, participating in receptor maturation, intracellular trafficking, recycling and physiological protein turnover.
On cell membrane surfaces, CSF2RA tends to assemble into heteromeric multiprotein complexes with other membrane localized receptor subunits and soluble extracellular signalling partners. The stability of these assembled complexes and the overall surface abundance of CSF2RA are dynamically governed by local membrane lipid environments, post translational modification status and the availability of matching molecular partners. Within laboratory research contexts, any disruption to CSF2RA protein integrity or expression magnitude can interfere with the assembly status of surface located multiprotein complexes, further changing measurable molecular outputs derived from membrane based receptor partner interactions. Hematopoietic active tissue microenvironments impose continuous adaptive requirements for cytokine triggered membrane receptor responses, which rely on properly assembled multimeric receptor configurations to maintain local membrane physiological homeostasis. Membrane tethered CSF2RA works cooperatively with adjacent membrane resident and intracellular binding partners to suppress undesired complex rearrangement and sustain stable plasma membrane molecular architectures.
Coding sequence alterations of CSF2RA may compromise overall protein folding efficiency, disrupt extracellular partner binding interfaces, destabilize transmembrane segment assembly and impair the docking capacity for intracellular effector components. Despite structural homology shared among other type I cytokine receptor subunits, paralogous receptors cannot replicate the full spectrum of CSF2RA specific partner binding features and tissue specific distribution patterns. Fluctuations in CSF2RA protein levels match the adaptive physiological demands of cytokine responsive tissues, making this receptor subunit a valuable research object for probing type I cytokine receptor mechanisms and hematopoietic relevant membrane homeostasis. Distributed between plasma membrane and intracellular vesicle fractions, CSF2RA containing receptor assemblies cannot sustain lasting downstream signalling events without adequate extracellular partner driven conformational rearrangement. Its distinct extracellular domain architecture differentiates CSF2RA from many other cell surface receptors, enabling selective and reversible molecular contacts with various binding subunits. Insufficient CSF2RA functional capacity may induce disorganization of surface multiprotein assemblies and weaken tissue level adaptive buffering performance.
Research oriented tools targeting CSF2RA support experimental assessment of receptor expression abundance, subcellular distribution and multiprotein complex formation. As a ligand binding subunit of type I cytokine transmembrane receptor, CSF2RA serves as a favourable research subject for exploring receptor trafficking behaviours, intermolecular partner recognition and membrane homeostasis regulatory mechanisms. Corresponding laboratory reagents enable systematic characterization of CSF2RA related molecular events under strictly controlled experimental conditions.
Fig. 1 Structural schematic of human CSF2RA (GM-CSF receptor α) with β-common subunit heteromeric assembly, showing extracellular FN-III domains (D1–D3), single transmembrane segment and membrane-anchored complex architecture. Receptor structure only; ligand binding and downstream signalling are not covered.1
The biological functions of transmembrane CSF2RA cytokine receptor subunit protein are focused on sustained heteromeric partner-complex interaction and membrane-receptor-homeostasis coordination:
Creative Biolabs offers purified CSF2RA membrane protein samples generated under unified preparation workflows, including full-length receptor constructs and isolated domain-truncated variants. Truncated domain fragments cannot support complete surface-partner-complex assembly behaviours, whereas full-length constructs suit research focused on partner-complex interaction and plasma-membrane-receptor-related functional observation. All batches receive uniform quality screening. Function-oriented observation may only be performed using full-length samples under simulated plasma-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length CSF2RA samples retain intact partner-interaction-domain conformation after standardized purification, supporting reliable detection of weak and transient receptor-partner contacts for comparative functional analysis.
Not finding the Membrane potein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable CSF2RA expression cell research models with tunable target-expression levels, applicable to structural observation of single-pass type-I cytokine receptor and research into membrane-partner molecular interaction. Sample evaluation includes sustained target-receptor expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of receptor-binding behaviours under differing target-protein abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-assembly efficiency alongside shifting CSF2RA protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-CSF2RA recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma-membrane localization mapping and identification of receptor-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realise multi-dimensional observation of target-receptor distribution within membrane-enriched sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for CSF2RA research:
CSF2RA might act as a single-pass type-I cytokine transmembrane receptor subunit and participate in heteromeric surface-complex assembly to modulate receptor-complex arrangement and membrane-receptor homeostasis.
CSF2RA expression status could alter surface-partner-complex assembly efficiency and local plasma-membrane-coupled molecular-interaction balance, serving as an important mediator of cytokine-receptor-associated membrane-homeostasis-related biological processes.
No, CSF2RA-associated research reagents from Creative Biolabs are exclusively built for exploring cytokine-receptor-family-dependent cell-surface regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length CSF2RA membrane protein, target-specific recombinant antibodies and tunable-expression cell research models, supporting research on membrane-receptor homeostasis and receptor-mediated membrane-partner perception.
Laboratory observation schemes may include receptor-partner-interaction related tests to analyse molecular-binding associated behaviours under simulated plasma-membrane environments.